A feasibility study of adjuvant therapy with UFT/Leucovorin+Oxaliplatin following curative resection for stage III colorectal cancer

ABSTRACT: Interventions: UFT 300mg per m2 per day and LV 75mg per day for 28 days Oxaliplatin:85mg/m2 day1,15 every 35 days for 5-cycle Primary outcome(s): Treatment completion ratio Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2631332 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR